Lenz Therapeutics Inc. (LENZ)

Market is closed

Hedge Fund Popularity

Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4202220230246810121416182022242628# of Hedge Fund PositionsShare Price - $25Avg. Share Price (Market)# of Hedge Fund Positions

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

0 $0 -100% 0%
2.
Samsara BioCapital

Srini Akkaraju And Michael Dybbs

0 $0 -100% 0%
3.
Prosight Capital

Lawrence Hawkins

0 $0 -100% 0%
4.
Millennium Management

Israel Englander

0 $0 -100% 0%
5. 0 $0 -100% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$15.68 3,188 Officer 3,188 2024-05-14 Filing
$15.99 31,332 Director 525,565 2024-05-13 Filing
$15.03 64,971 694,755 2024-03-21 Filing
$15.03 933,038 3,319,339 2024-03-21 Filing
$4.08 350,000 Large Shareholder 8,459,314 2022-04-12 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 251,431.28,571,429 $4,611,249 0%
2. 203,711.42,857,143 $3,736,068 0%
3. 100,438.71,428,571 $1,842,046 0.11%
4. 79,307.571,428,571 $1,454,675 0%
5. 63,916.571,428,571 $1,172,230 0.88%
News See All